CD4 and Alzheimer disease: NK cell activity has been proposed as a biomarker for the progression of AD[65,66].Conversely, we observed a significant reduction in the infiltration of effector memory CD4 T cells and eosinophils in AD patients, suggesting a potential protective or dysregulated function of these cells in disease modulation.